V
Vifor Pharma AG
SIX:VIFN
Vifor Pharma AG
SIX:VIFN
Price:
166.15 CHF
0.48%
Market Closed
Updated:
May 2, 2024
Vifor Pharma AG
Cash from Operating Activities
|
Vifor Pharma AG
Cash from Operating Activities Peer Comparison
Comparables:
NOVN
NLSP
ROG
S
SDZ
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
V
|
Vifor Pharma AG
SIX:VIFN
|
Cash from Operating Activities
CHf527.3m
|
CAGR 3-Years
40%
|
CAGR 5-Years
15%
|
CAGR 10-Years
5%
|
|
|
Novartis AG
SIX:NOVN
|
Cash from Operating Activities
$14.5B
|
CAGR 3-Years
2%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
|
|
NLS Pharmaceutics AG
NASDAQ:NLSP
|
Cash from Operating Activities
-$13.9m
|
CAGR 3-Years
-318%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
N/A
|
|
|
Roche Holding AG
SIX:ROG
|
Cash from Operating Activities
CHf16.1B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
0%
|
|
S
|
Sandoz Group AG
SIX:SDZ
|
Cash from Operating Activities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Vifor Pharma AG's Cash from Operating Activities?
Cash from Operating Activities
527.3m
CHF
527.3m
CHF
Based on the financial report for Dec 31, 2021, Vifor Pharma AG's Cash from Operating Activities amounts to 527.3m CHF.
What is Vifor Pharma AG's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
5%
5%
Over the last year, the Cash from Operating Activities growth was 24%. The average annual Cash from Operating Activities growth rates for Vifor Pharma AG have been 40% over the past three years , 15% over the past five years , and 5% over the past ten years .
You don't have any saved screeners yet
